
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,300 peer-reviewed publications.
The CPRD bibliography is updated on a monthly basis (last updated 4 November 2019) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 3MB, 192 pages)
“Clinical profile of predefined asthma phenotypes in a large cohort of UK primary care patients (Clinical Practice Research Datalink)”, J Asthma Allergy, vol. 12, pp. 7-19, 2019.
, “Clinical relevance of thrombocytosis in primary care: a prospective cohort study of cancer incidence using English electronic medical records and cancer registry data”, Br J Gen Pract, vol. 67, pp. e405-e413, 2017.
, “A clinical research practice datalink analysis of antidepressant treatment patterns and health care costs in generalized anxiety disorder”, Value Health, vol. 16, pp. 1133-9, 2013.
, “Clinical risk factors for venous thromboembolus in users of the combined oral contraceptive pill”, Br J Clin Pharmacol, vol. 53, pp. 637-40, 2002.
, “Clinical workload in UK primary care: a retrospective analysis of 100 million consultations in England, 2007-14”, Lancet, vol. 387, pp. 2323-2330, 2016.
, “ClinicalCodes: an online clinical codes repository to improve the validity and reproducibility of research using electronic medical records”, PLoS One, vol. 9, p. e99825, 2014.
, “Clobazam and clonazepam use in epilepsy: Results from a UK database incident user cohort study”, Epilepsy Res, vol. 123, pp. 68-74, 2016.
, “Clopidogrel and interaction with proton pump inhibitors: comparison between cohort and within person study designs”, Bmj, vol. 345, p. e4388, 2012.
, “Clopidogrel discontinuation after acute coronary syndromes: frequency, predictors and associations with death and myocardial infarction–a hospital registry-primary care linked cohort (MINAP-GPRD)”, Eur Heart J, vol. 32, pp. 2376-86, 2011.
, “Clopidogrel use and cancer-specific mortality: a population-based cohort study of colorectal, breast and prostate cancer patients”, Pharmacoepidemiol Drug Saf, vol. 24, pp. 830-40, 2015.
, “Closing the mortality gap after a myocardial infarction in people with and without chronic obstructive pulmonary disease”, Heart, vol. 101, pp. 1103-10, 2015.
, “Cluster randomised trial in the General Practice Research Database: 1. Electronic decision support to reduce antibiotic prescribing in primary care (eCRT study)”, Trials, vol. 12, p. 115, 2011.
, “Cluster randomized trial in the general practice research database: 2. Secondary prevention after first stroke (eCRT study): study protocol for a randomized controlled trial”, Trials, vol. 13, p. 181, 2012.
, “Cluster randomized trials utilizing primary care electronic health records: methodological issues in design, conduct, and analysis (eCRT Study)”, Trials, vol. 15, p. 220, 2014.
, “Co-administration of statins with cytochrome P450 3A4 inhibitors in a UK primary care population”, Pharmacoepidemiol Drug Saf, vol. 21, pp. 485-93, 2012.
, “Coding algorithms for defining Charlson and Elixhauser co-morbidities in Read-coded databases”, BMC Med Res Methodol, vol. 19, p. 115, 2019.
, “Coding, recording and incidence of different forms of coronary heart disease in primary care”, PLoS One, vol. 7, p. e29776, 2012.
, “Cohort profile for the MASTERMIND study: using the Clinical Practice Research Datalink (CPRD) to investigate stratification of response to treatment in patients with type 2 diabetes”, BMJ Open, vol. 7, p. e017989, 2017.
, “A cohort study of comorbidity in patients with granulomatosis with polyangiitis”, Rheumatology (Oxford), vol. 57, pp. 291-299, 2018.
, “Cohort study of preoperative blood pressure and risk of 30-day mortality after elective non-cardiac surgery”, Br J Anaesth, vol. 119, pp. 65-77, 2017.
, “A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database”, J Infect Dis, vol. 190, pp. 1-10, 2004.
, “A cohort study of the ocular safety of anti-ulcer drugs”, Br J Clin Pharmacol, vol. 42, pp. 213-6, 1996.
, “A cohort study on the risk of acute liver injury among users of ketoconazole and other antifungal drugs”, Br J Clin Pharmacol, vol. 48, pp. 847-52, 1999.
, “A cohort study on the risk of lymphoma and skin cancer in users of topical tacrolimus, pimecrolimus, and corticosteroids (Joint European Longitudinal Lymphoma and Skin Cancer Evaluation - JOELLE study)”, Clin Epidemiol, vol. 10, pp. 299-310, 2018.
, “Colorectal cancer and markers of anemia”, Eur J Cancer Prev, vol. 27, pp. 530-538, 2018.
, “Colorectal cancer incidence on the General Practice Research Database”, Pharmacoepidemiol Drug Saf, vol. 21, pp. 775-783, 2012.
, “Colorectal cancer risk reduction following macrogol exposure: a cohort and nested case control study in the UK”, PLoS One, vol. 8, p. e83203, 2013.
, “The combination of DPP-4 inhibitors versus sulfonylureas with metformin after failure of first-line treatment in the risk for major cardiovascular events and death”, Can J Diabetes, vol. 39, pp. 383-9, 2015.
, “Combination therapy with metformin plus sulphonylureas versus metformin plus DPP-4 inhibitors: association with major adverse cardiovascular events and all-cause mortality”, Diabetes Obes Metab, vol. 16, pp. 977-83, 2014.
, “Combination therapy with sulfonylureas and metformin and the prevention of death in type 2 diabetes: a nested case-control study”, Pharmacoepidemiol Drug Saf, vol. 19, pp. 335-42, 2010.
, “A combined connectivity mapping and pharmacoepidemiology approach to identify existing medications with breast cancer causing or preventing properties”, Pharmacoepidemiol Drug Saf, vol. 27, pp. 78-86, 2018.
, “Combined oral contraceptive use and the risk of systemic lupus erythematosus”, Arthritis Rheum, vol. 61, pp. 476-81, 2009.
, “Common mental disorders within chronic inflammatory disorders: a primary care database prospective investigation”, Ann Rheum Dis, 2019.
, “Commonly used definitions in real-world studies may underestimate the prevalence of renal disease among nonvalvular atrial fibrillation patients”, J Comp Eff Res, 2019.
, “Commonly used medications and endometrial cancer survival: a population-based cohort study”, Br J Cancer, vol. 117, pp. 432-438, 2017.
, “Community acquired pneumonia incidence before and after proton pump inhibitor prescription: population based study”, Bmj, vol. 355, p. i5813, 2016.
, “Community care in England: reducing socioeconomic inequalities in heart failure”, Circulation, vol. 126, pp. 1050-7, 2012.
, “Comorbid conditions delay diagnosis of colorectal cancer: a cohort study using electronic primary care records”, Br J Cancer, vol. 116, pp. 1536-1543, 2017.
, “Comorbidities affect risk of nonvariceal upper gastrointestinal bleeding”, Gastroenterology, vol. 144, pp. 1384-93, 1393.e1-2; quiz e18-9, 2013.
, “Comorbidities and Concomitant Medication Use in Men with Prostate Cancer or High Levels of PSA Compared to Matched Controls: A GPRD Analysis”, J Cancer Epidemiol, vol. 2012, p. 291704, 2012.
, “Comorbidities, bone-sparing agent prescription history and their determinants among postmenopausal women in UK primary care settings: a retrospective database study”, Arch Osteoporos, vol. 10, p. 41, 2015.
, “Comorbidities in patients with gout prior to and following diagnosis: case-control study”, Ann Rheum Dis, vol. 75, pp. 210-7, 2016.
, “Comorbidities in Perthes' disease: a case control study using the General Practice Research database”, J Bone Joint Surg Br, vol. 94, pp. 1684-9, 2012.
, “Comorbidities of idiopathic thrombocytopenic purpura: a population-based study”, Adv Hematol, vol. 2009, p. 963506, 2009.
, “Comorbidity Burden in Trial-Aligned Patients with Established Gout in Germany, UK, US, and France: a Retrospective Analysis”, Adv Ther, vol. 33, pp. 1180-98, 2016.
, “The comorbidity burden of type 2 diabetes mellitus: patterns, clusters and predictions from a large English primary care cohort”, BMC Med, vol. 17, p. 145, 2019.
, “Comorbidity in multiple sclerosis: its temporal relationships with disease onset and dose effect on mortality”, Eur J Neurol, 2019.
, “Comparability of the age and sex distribution of the UK Clinical Practice Research Datalink and the total Dutch population”, Pharmacoepidemiol Drug Saf, vol. 25, pp. 1460-1464, 2016.
, “Comparative anti-fracture effectiveness of different oral anti-osteoporosis therapies based on "real-world" data: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database”, Clin Epidemiol, vol. 10, pp. 1417-1431, 2018.
, “Comparative benefit of malaria chemoprophylaxis modelled in United Kingdom travellers”, Travel Med Infect Dis, vol. 12, pp. 726-32, 2014.
,